Back

Epidemiological Association of Cannabinoid- and Drug- Exposures and Sociodemographic Factors with Limb Reduction Defects Across USA 1989-2016: A Geotemporospatial and Causal Inference Study

Reece, A. S.; Hulse, G. K.

2020-09-03 pediatrics
10.1101/2020.09.01.20186163
Show abstract

Reports of major limb defects after prenatal cannabis exposure (PCE) in animals and of human populations in Hawaii, Europe and Australia raise the question of whether the increasing use of cannabis in USA might be spatiotemporally associated with limb reduction rates (LRR) across USA. Geotemporospatial analysis conducted in R. LRR was significantly associated with cannabis use and THC potency and demonstrated prominent cannabis-use quintile effects. In final lagged geospatial models interactive terms including cannabinoids were highly significant and robust to adjustment. States in which cannabis was not legalized had a lower LRR (4.28 v 5.01 /10,000 live births, relative risk reduction = -0.15, (95%C.I. -0.25, -0.02), P=0.021). 37-63% of cases are estimated to not be born alive; their inclusion strengthened these associations. Causal inference studies using inverse probabilty-weighted robust regression and e-values supported causal epidemiological pathways. Findings apply to several cannabinoids, are consistent with pathophysiological and causal mechanisms, are exacerbated by cannabis legalization and demonstrate dose-related intergenerational sequaelae. HighlightsO_LILimb reduction rates (LRR) were associated with cannabis use, and THC potency C_LIO_LIThese relationships were robust to adjustment for ethic and economic covariates C_LIO_LIThey were maintained at geospatiotemporal regression C_LIO_LILRR elevated as stillborn and aborted cases were considered C_LIO_LICriteria of causality was fulfilled C_LI

Matching journals

The top 12 journals account for 50% of the predicted probability mass.

1
Spatial and Spatio-temporal Epidemiology
based on 10 papers
Top 0.1%
7.9%
2
Scientific Reports
based on 701 papers
Top 27%
6.7%
3
JAMA Network Open
based on 125 papers
Top 2%
6.1%
4
PLOS ONE
based on 1737 papers
Top 67%
5.3%
5
Pediatric Research
based on 15 papers
Top 0.5%
4.7%
6
Journal of the American Heart Association
based on 92 papers
Top 5%
4.7%
7
Addiction Biology
based on 13 papers
Top 0.4%
3.1%
8
BMJ Open
based on 553 papers
Top 29%
2.9%
9
Annals of Neurology
based on 43 papers
Top 2%
2.6%
10
NeuroImage: Clinical
based on 77 papers
Top 4%
2.4%
11
Psychological Medicine
based on 52 papers
Top 4%
2.4%
12
PLOS Medicine
based on 95 papers
Top 7%
1.9%
50% of probability mass above
13
Developmental Cognitive Neuroscience
based on 14 papers
Top 0.4%
1.9%
14
Nature Medicine
based on 88 papers
Top 6%
1.8%
15
Translational Psychiatry
based on 94 papers
Top 6%
1.6%
16
BMC Medicine
based on 155 papers
Top 14%
1.4%
17
International Journal of Obesity
based on 17 papers
Top 2%
1.4%
18
Psychoneuroendocrinology
based on 12 papers
Top 0.3%
1.4%
19
Human Reproduction
based on 11 papers
Top 1%
1.4%
20
Frontiers in Neurology
based on 74 papers
Top 9%
1.4%
21
eLife
based on 262 papers
Top 20%
1.4%
22
Biological Psychiatry
based on 36 papers
Top 4%
1.3%
23
American Journal of Psychiatry
based on 14 papers
Top 1%
1.3%
24
Clinical Epigenetics
based on 21 papers
Top 1%
1.3%
25
Hypertension
based on 20 papers
Top 3%
1.3%
26
Journal of Neurotrauma
based on 11 papers
Top 2%
0.8%
27
Obesity
based on 11 papers
Top 2%
0.8%
28
BMC Public Health
based on 148 papers
Top 21%
0.8%
29
Drug and Alcohol Dependence
based on 21 papers
Top 1%
0.8%
30
Frontiers in Genetics
based on 32 papers
Top 5%
0.8%